126 related articles for article (PubMed ID: 37738403)
21. DRdriver: identifying drug resistance driver genes using individual-specific gene regulatory network.
Huang YE; Zhou S; Liu H; Zhou X; Yuan M; Hou F; Chen S; Chen J; Wang L; Jiang W
Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36869849
[TBL] [Abstract][Full Text] [Related]
22. An integrated approach to uncover driver genes in breast cancer methylation genomes.
Shen X; Li S; Zhang L; Li H; Hong G; Zhou X; Zheng T; Zhang W; Hao C; Shi T; Liu C; Guo Z
PLoS One; 2013; 8(4):e61214. PubMed ID: 23579546
[TBL] [Abstract][Full Text] [Related]
23. Prioritization of cancer driver gene with prize-collecting steiner tree by introducing an edge weighted strategy in the personalized gene interaction network.
Zhang SW; Wang ZN; Li Y; Guo WF
BMC Bioinformatics; 2022 Aug; 23(1):341. PubMed ID: 35974311
[TBL] [Abstract][Full Text] [Related]
24. High-resolution genomic and expression analyses of copy number alterations in breast tumors.
Haverty PM; Fridlyand J; Li L; Getz G; Beroukhim R; Lohr S; Wu TD; Cavet G; Zhang Z; Chant J
Genes Chromosomes Cancer; 2008 Jun; 47(6):530-42. PubMed ID: 18335499
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic driver mutations in lung cancer.
Luo SY; Lam DC
Transl Respir Med; 2013 Dec; 1(1):6. PubMed ID: 27234388
[TBL] [Abstract][Full Text] [Related]
26. Unravelling cancer subtype-specific driver genes in single-cell transcriptomics data with CSDGI.
Huang M; Ma J; An G; Ye X
PLoS Comput Biol; 2023 Dec; 19(12):e1011450. PubMed ID: 38096269
[TBL] [Abstract][Full Text] [Related]
27. A systematic view of computational methods for identifying driver genes based on somatic mutation data.
Kan Y; Jiang L; Tang J; Guo Y; Guo F
Brief Funct Genomics; 2021 Sep; 20(5):333-343. PubMed ID: 34312663
[TBL] [Abstract][Full Text] [Related]
28. Mutational Profiling of Driver Tumor Suppressor and Oncogenic Genes in Brazilian Malignant Pleural Mesotheliomas.
Campanella NC; Silva EC; Dix G; de Lima Vazquez F; Escremim de Paula F; Berardinelli GN; Balancin M; Chammas R; Mendoza Lopez RV; Silveira HCS; Capelozzi VL; Reis RM
Pathobiology; 2020; 87(3):208-216. PubMed ID: 32369821
[TBL] [Abstract][Full Text] [Related]
29. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.
Guo WF; Zhang SW; Liu LL; Liu F; Shi QQ; Zhang L; Tang Y; Zeng T; Chen L
Bioinformatics; 2018 Jun; 34(11):1893-1903. PubMed ID: 29329368
[TBL] [Abstract][Full Text] [Related]
30. Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.
Zhang G; Wang Y; Chen B; Guo L; Cao L; Ren C; Wen L; Li K; Jia M; Li C; Mok H; Chen X; Wei G; Lin J; Zhang Z; Hou T; Han-Zhang H; Liu C; Liu H; Liu J; Balch CM; Meric-Bernstam F; Liao N
Ann Transl Med; 2019 Apr; 7(8):179. PubMed ID: 31168460
[TBL] [Abstract][Full Text] [Related]
31. Exomes of Ductal Luminal Breast Cancer Patients from Southwest Colombia: Gene Mutational Profile and Related Expression Alterations.
Cortes-Urrea C; Bueno-Gutiérrez F; Solarte M; Guevara-Burbano M; Tobar-Tosse F; Vélez-Varela PE; Bonilla JC; Barreto G; Velasco-Medina J; Moreno PA; Rivas JL
Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365829
[TBL] [Abstract][Full Text] [Related]
32. Functional analysis of non-hotspot AKT1 mutants found in human breast cancers identifies novel driver mutations: implications for personalized medicine.
Yi KH; Axtmayer J; Gustin JP; Rajpurohit A; Lauring J
Oncotarget; 2013 Jan; 4(1):29-34. PubMed ID: 23237847
[TBL] [Abstract][Full Text] [Related]
33. Cooperative driver pathway discovery via fusion of multi-relational data of genes, miRNAs and pathways.
Wang J; Yang Z; Domeniconi C; Zhang X; Yu G
Brief Bioinform; 2021 Mar; 22(2):1984-1999. PubMed ID: 32103253
[TBL] [Abstract][Full Text] [Related]
34. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
[TBL] [Abstract][Full Text] [Related]
35. Sparse overlapping group lasso for integrative multi-omics analysis.
Park H; Niida A; Miyano S; Imoto S
J Comput Biol; 2015 Feb; 22(2):73-84. PubMed ID: 25629319
[TBL] [Abstract][Full Text] [Related]
36. Identifying cancer patient subgroups by finding co-modules from the driver mutation profiles and downstream gene expression profiles.
Song J; Peng W; Wang F
IEEE/ACM Trans Comput Biol Bioinform; 2021 Aug; PP():. PubMed ID: 34415837
[TBL] [Abstract][Full Text] [Related]
37. A Graph Convolution Network-Based Model for Prioritizing Personalized Cancer Driver Genes of Individual Patients.
Peng W; Yu P; Dai W; Fu X; Liu L; Pan Y
IEEE Trans Nanobioscience; 2023 Oct; 22(4):744-754. PubMed ID: 37195839
[TBL] [Abstract][Full Text] [Related]
38. Latent space search based multimodal optimization with personalized edge-network biomarker for multi-purpose early disease prediction.
Liang J; Li ZW; Sun ZN; Bi Y; Cheng H; Zeng T; Guo WF
Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37833844
[TBL] [Abstract][Full Text] [Related]
39. Oncogenic long noncoding RNA landscape in breast cancer.
Xu S; Kong D; Chen Q; Ping Y; Pang D
Mol Cancer; 2017 Jul; 16(1):129. PubMed ID: 28738804
[TBL] [Abstract][Full Text] [Related]
40. miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs.
Riaz M; van Jaarsveld MT; Hollestelle A; Prager-van der Smissen WJ; Heine AA; Boersma AW; Liu J; Helmijr J; Ozturk B; Smid M; Wiemer EA; Foekens JA; Martens JW
Breast Cancer Res; 2013 Apr; 15(2):R33. PubMed ID: 23601657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
